In CAC models, PINK1 hampers tumor growth by activating p53 and HIF-1α/PDHK1/PDHE1α pathways, reducing acetyl-CoA production; contrastingly, acetate exposure increases acetyl-CoA in tumors, counteracting PINK1’s anti-tumorigenic effects (225). The gene discussed is PINK1; the disease is neoplasm.